PHODABRA (Dabrafenib) 75mg | Generic BRAF Inhibitor | Pharma 2 Vientiane | GLT

PHODABRA is a generic dabrafenib produced by Pharma 2 Vientiane, the second state pharmaceutical factory in Vientiane, Laos. It provides the same 75 mg dabrafenib capsule as the originator at a markedly lower price, making BRAF-targeted therapy more accessible. Note that this facility is sometimes flagged online with the word "discontinued"; in fact the plant has completed remediation and is operating normally, with current production available through GLT.

Generic Information: PHODABRA (Dabrafenib)

Pharma 2 Vientiane (State Pharmaceutical Factory No. 2) is one of Laos's principal public-sector drug manufacturers. It produces a range of generic oncology and specialty medicines under Good Manufacturing Practice standards and supplies both the domestic Lao market and export channels. PHODABRA is its dabrafenib offering, named to signal the active molecule while remaining a distinct brand.

What Is PHODABRA (Dabrafenib) Used For?

As a dabrafenib, PHODABRA is for cancers driven by a BRAF V600 mutation: advanced or metastatic melanoma, and — together with trametinib — BRAF V600E-mutated metastatic non-small cell lung cancer and anaplastic thyroid cancer. The active ingredient and its dosing are identical to the originator.

How Does PHODABRA Work?

PHODABRA delivers dabrafenib, which binds the mutated BRAF kinase and shuts down the overactive MAPK signal that BRAF-mutant tumors use to grow. Blocking that pathway slows tumor progression and can trigger cancer-cell death. The generic therefore reproduces the originator's mechanism of action at lower cost.

Indications

• Unresectable or metastatic BRAF V600-mutant melanoma
• Adjuvant melanoma therapy with trametinib
• BRAF V600E metastatic NSCLC with trametinib
• BRAF V600E anaplastic thyroid cancer with trametinib

Dosage & Administration

The standard dose is 150 mg twice daily, taken as two 75 mg capsules each time, with or without food. Capsules are swallowed whole with water. The 75 mg strength in this listing is the one used to make up the standard dose.

Side Effects

Expect the same side-effect profile as the originator: fever, fatigue, rash, nausea, headache, chills and joint pain are common. Serious risks include new skin cancers, bleeding, heart problems, eye inflammation and high blood sugar. Skin checks and fever monitoring remain important.

Storage & Handling

Keep capsules at room temperature in the original packaging, protected from moisture and light, and out of children's reach. Do not use after the expiry date.

Why Choose PHODABRA?

• Lower-cost generic — the same dabrafenib at a fraction of the originator price.
• State-owned Lao manufacturer — Pharma 2 Vientiane with GMP production.
• Available supply — the plant is operating normally; GLT sources current batches.

How to Order PHODABRA from GLT

1. Contact GLT via WhatsApp +86 15234153837 or email [email protected] with your required quantity.
2. Receive a quotation and delivery schedule.
3. Complete payment via Hao Yi Lian / 好易联.
4. Shipment dispatches with documentation and tracking.

A valid prescription may be requested before dispatch. We serve institutions and individual patients.

FAQ

1. Is PHODABRA still available?

Yes. The Lao Pharma 2 plant has completed remediation and is producing normally; GLT supplies current batches of PHODABRA.

2. Is PHODABRA the same as Tafinlar?

It is a generic containing the same 75 mg dabrafenib active ingredient, manufactured by a different company.

3. Do I need a prescription?

Yes, dabrafenib requires a prescription, which may be requested before dispatch.